Training activity information
Details
Perform local laboratory methods for HLA antibody detection and definition
Type
Entrustable training activity (ETA)
Evidence requirements
Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion.
Reflection at multiple timepoints on the trainee learning journey for this activity.
Considerations
- Principles of HLA antibody production
- Sources of HLA sensitisation
- Selection and principles of laboratory methods for HLA antibody detection and definition
- Assay operational and performance characteristics
- Internal quality controls and external quality assessment measures
- Method limitations
- Troubleshooting
- Clinical significance of HLA and non- HLA antibodies in transplantation
- Infection control
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
What does success look like?
- Identify what is expected of you in relation to successfully performing local laboratory methods for detecting and defining HLA antibodies (e.g., using solid phase assays like Luminex).
- Consider how the learning outcomes apply, specifically in relation to applying the appropriate testing strategy, performing the relevant laboratory investigations, and practicing in accordance with quality standards.
- Discuss with your training officer to gain clarity of what is expected of you in relation to sample handling, adherence to kit instructions, instrument operation (e.g., bead counting limits), and required quality control parameters.
What is your prior experience of this activity?
- Think about what you already know about immunology assays, working with specialised reagents (e.g., antibody-coated beads), and operating sensitive analytical equipment.
- Consider possible challenges you might face during the activity, such as technical failures with the analyser, unexpected control values (e.g., positive or negative controls out of range), or encountering non-specific reactivity.
- Recognise the scope of your own practice for this activity i.e. know when you will need to seek advice or help, and from whom. You will need to seek advice from your Training Officer when required, for example if the instrument generates persistent errors or if quality control results violate the acceptance criteria, necessitating specialist troubleshooting.
- Acknowledge how you feel about performing a technically complex assay that is critical for transplant risk assessment.
What do you anticipate you will learn from the experience?
- Consider the specific skills you want to develop, such as meticulous plate preparation to minimise cross-contamination or advanced troubleshooting of analyser errors.
- Identify the specific insights you hope to gain into the technical nuances and limitations of solid phase antibody assays.
What additional considerations do you need to make?
- Consult actions identified following previous experiences of performing complex immunoassays or troubleshooting laboratory instrumentation.
- Identify important information you need to consider before embarking on the activity, such as reviewing the specific assay protocol steps, verifying reagent lot integrity, and clarifying the criteria for a valid assay run.
In action
Is anything unexpected occurring?
- Are you noticing anything surprising or different from what you anticipate whilst performing the HLA antibody detection and definition assay?
- Are you encountering situations such as:
- Assays showing unexpected reactivity patterns e.g., generalised high background, prozone effect, or unexpected negative controls?
- Technical issues arising with reagents, beads, or the Luminex analyser e.g., fluidics issue, calibration error?
- The raw data acquisition or initial processing being different from anticipated (e.g., low bead counts)?
How are you reacting to the unexpected development?
- How is this impacting your actions? For example, are you responding to the situation appropriately? Are you adapting or changing your approach to troubleshooting the assay performance?
- Consider the steps you are taking in the moment, such as:
- Immediately re-running control samples or reviewing the instrument log files to identify the source of the error
- Adapting the sample handling technique to mitigate potential prozone effects based on previous experience
- How are you feeling in that moment? For instance, are you finding it difficult to troubleshoot a persistent analyser issue? Is it affecting your confidence in performing the antibody assay independently and reliably?
What is the conclusion or outcome?
- Identify how you are working within your scope of practice. For example, are you successfully performing minor troubleshooting steps to complete the assay according to protocol? Or are you needing support because the assay quality controls fail persistently, requiring a technical specialist intervention?
- What are you learning as a result of the unexpected development? For example, are you mastering the technical troubleshooting steps for the Luminex analyser? Or gaining insight into how reagent quality affects assay reliability?
On action
What happened?
- Begin by summarising the key steps you took when performing the HLA antibody detection and definition method(s).
- Consider specific events, actions, or interactions which felt important, such as how you prepared the sample plate, ran the Luminex analyser, or performed quality control checks.
- Include any ‘reflect-in-action’ moments where you had to adapt to the situation as it unfolded, for instance, immediately halting the run to troubleshoot a fluidics error or adjusting the bead wash steps when initial quality metrics suggested background noise.
- How did you feel during this experience, e.g., did you feel methodical about plate preparation or stressed by equipment technical demands?
How has this experience contributed to your developing practice?
- Identify what learning you can take from this experience regarding performing HLA antibody testing methods. What strengths did you demonstrate, e.g., adherence to quality control checks?
- What skills and/or knowledge gaps were evident, e.g., troubleshooting complex analyser errors or managing prozone effects?
- Compare this experience against previous engagement with similar activities – were any previously identified actions for development achieved? Has your practice improved in performing the relevant laboratory investigations?
- Identify any challenges you experienced, such as unexpected MFI values, kit component issues, or needing advice on managing prozone effects, and how you reacted to this.
What will you take from the experience moving forward?
- Identify the actions or ‘next steps’ you will now take to support the assimilation of what you have learnt, including from any feedback you have received, with regards to improving your proficiency with HLA antibody detection and definition methods.
- What will you do differently next time you approach performing these tests, for instance, by proactively double-checking reagent temperatures before setup?
- Do you need to practise any aspect of the activity further, such as specific parts of the assay or key learning outcomes related to applying the appropriate testing strategy?
Beyond action
Have you revisited the experiences?
- How have your subsequent experiences of performing local laboratory methods for HLA antibody detection and definition since completing this specific training activity led you to revisit your initial approach or decisions during that activity? For example, how a subsequent run showing non-specific reactivity due to poor wash steps forced you to re-evaluate the diligence of your technical technique and reagent preparation during your first attempt at this training activity.
- Considering what you understand about assay variables (e.g., wash steps, bead handling), quality control requirements, and common causes of false results now, were the actions or considerations you identified after your initial reflection on this training activity sufficient?
- How have you since implemented or adapted improvements in your technical technique or data acquisition based on further learning and experiences? For example, how you proactively reviewed and implemented a standardised checklist for Luminex analyser fluidics checks based on further learning.
- Has discussing the principles behind different antibody detection methods or the impact of assay variables on results with colleagues, peers, or supervisors changed how you now view your initial experience in this training activity? For example, how professional storytelling with a senior colleague about a time when a prozone effect necessitated sample dilution and re-testing refined your understanding of the critical nature of troubleshooting and understanding assay limitations during antibody testing.
How have these experiences impacted upon current practice?
- How has the learning from this initial training activity, in combination with subsequent experiences of antibody assay performance, contributed to your overall confidence and competence in executing HLA antibody assays reliably, particularly in preparing for observed assessments (DOPS or OCEs) such as ‘Perform tests for HLA antibody specification’? For example, how your accumulated ability in precise technique and troubleshooting now enables you to manage technical challenges confidently during a DOPS assessment.
- How has reflecting back on this specific training activity, combined with everything you’ve learned since, shaped your current approach to antibody detection methods?
- How does this evolved understanding help you identify when an antibody assay has failed, produced ambiguous results, or requires repeat testing and when this requires expert review? For example, how your evolved approach means you now routinely seek expert review immediately when persistent control failures indicate a major equipment or reagent issue, recognising this falls outside routine technical scope.
- Looking holistically at your training journey, how has this initial antibody detection experience, revisited with your current perspective, contributed to your development in meeting the learning outcomes related to applying the appropriate testing strategy and performing relevant investigations? For example, how this foundational experience has supported your development in transferable skills such as understanding immunological principles and working within a quality framework that will be valuable in future roles or responsibilities.
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 2 |
Outcome
Apply the appropriate testing strategy for patients referred for solid organ transplantation, haematopoietic stem cell transplantation, HLA associated diseases and pharmacogenetic reactions. |
| # 3 |
Outcome
Perform the relevant laboratory investigations for a range of patients referred to an H&I laboratory. |
| # 6 |
Outcome
Practice in accordance with quality and accreditation standards. |